These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 26100227)
1. Disturbance of gene expression in primary human hepatocytes by hepatotoxic pyrrolizidine alkaloids: A whole genome transcriptome analysis. Luckert C; Hessel S; Lenze D; Lampen A Toxicol In Vitro; 2015 Oct; 29(7):1669-82. PubMed ID: 26100227 [TBL] [Abstract][Full Text] [Related]
2. Hepatotoxic pyrrolizidine alkaloids induce DNA damage response in rat liver in a 28-day feeding study. Ebmeyer J; Rasinger JD; Hengstler JG; Schaudien D; Creutzenberg O; Lampen A; Braeuning A; Hessel-Pras S Arch Toxicol; 2020 May; 94(5):1739-1751. PubMed ID: 32419051 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship in the passage of different pyrrolizidine alkaloids through the gastrointestinal barrier: ABCB1 excretes heliotrine and echimidine. Hessel S; Gottschalk C; Schumann D; These A; Preiss-Weigert A; Lampen A Mol Nutr Food Res; 2014 May; 58(5):995-1004. PubMed ID: 24375927 [TBL] [Abstract][Full Text] [Related]
4. Structure-dependent induction of apoptosis by hepatotoxic pyrrolizidine alkaloids in the human hepatoma cell line HepaRG: Single versus repeated exposure. Waizenegger J; Braeuning A; Templin M; Lampen A; Hessel-Pras S Food Chem Toxicol; 2018 Apr; 114():215-226. PubMed ID: 29458164 [TBL] [Abstract][Full Text] [Related]
5. Pyrrolizidine alkaloid-induced alterations of prostanoid synthesis in human endothelial cells. Ebmeyer J; Behrend J; Lorenz M; Günther G; Reif R; Hengstler JG; Braeuning A; Lampen A; Hessel-Pras S Chem Biol Interact; 2019 Jan; 298():104-111. PubMed ID: 30465738 [TBL] [Abstract][Full Text] [Related]
7. Assessment of pyrrolizidine alkaloid-induced toxicity in an in vitro screening model. Li YH; Kan WL; Li N; Lin G J Ethnopharmacol; 2013 Nov; 150(2):560-7. PubMed ID: 24045176 [TBL] [Abstract][Full Text] [Related]
8. Pyrrolizidine alkaloid-induced transcriptomic changes in rat lungs in a 28-day subacute feeding study. Buchmueller J; Sprenger H; Ebmeyer J; Rasinger JD; Creutzenberg O; Schaudien D; Hengstler JG; Guenther G; Braeuning A; Hessel-Pras S Arch Toxicol; 2021 Aug; 95(8):2785-2796. PubMed ID: 34185104 [TBL] [Abstract][Full Text] [Related]
9. Active Transport of Hepatotoxic Pyrrolizidine Alkaloids in HepaRG Cells. Enge AM; Kaltner F; Gottschalk C; Braeuning A; Hessel-Pras S Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917053 [TBL] [Abstract][Full Text] [Related]
10. Pyrrolizidine alkaloids cause cell cycle and DNA damage repair defects as analyzed by transcriptomics in cytochrome P450 3A4-overexpressing HepG2 clone 9 cells. Abdelfatah S; Naß J; Knorz C; Klauck SM; Küpper JH; Efferth T Cell Biol Toxicol; 2022 Apr; 38(2):325-345. PubMed ID: 33884520 [TBL] [Abstract][Full Text] [Related]
11. The pyrrolizidine alkaloid senecionine induces CYP-dependent destruction of sinusoidal endothelial cells and cholestasis in mice. Hessel-Pras S; Braeuning A; Guenther G; Adawy A; Enge AM; Ebmeyer J; Henderson CJ; Hengstler JG; Lampen A; Reif R Arch Toxicol; 2020 Jan; 94(1):219-229. PubMed ID: 31606820 [TBL] [Abstract][Full Text] [Related]
12. Structure-dependent hepato-cytotoxic potencies of selected pyrrolizidine alkaloids in primary rat hepatocyte culture. Gao L; Rutz L; Schrenk D Food Chem Toxicol; 2020 Jan; 135():110923. PubMed ID: 31672516 [TBL] [Abstract][Full Text] [Related]
13. Metabolic Pattern of Hepatotoxic Pyrrolizidine Alkaloids in Liver Cells. Geburek I; Rutz L; Gao L; Küpper JH; These A; Schrenk D Chem Res Toxicol; 2021 Apr; 34(4):1101-1113. PubMed ID: 33719395 [TBL] [Abstract][Full Text] [Related]
15. Metabolomic and genomic evidence for compromised bile acid homeostasis by senecionine, a hepatotoxic pyrrolizidine alkaloid. Xiong A; Yang F; Fang L; Yang L; He Y; Wan YJ; Xu Y; Qi M; Wang X; Yu K; Tsim KW; Wang Z Chem Res Toxicol; 2014 May; 27(5):775-86. PubMed ID: 24641316 [TBL] [Abstract][Full Text] [Related]
16. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753 [TBL] [Abstract][Full Text] [Related]
17. Pyrrolizidine Alkaloids Induce Cell Death in Human HepaRG Cells in a Structure-Dependent Manner. Glück J; Waizenegger J; Braeuning A; Hessel-Pras S Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379168 [TBL] [Abstract][Full Text] [Related]
18. Transcriptomics of Hepatocytes Treated with Toxicants for Investigating Molecular Mechanisms Underlying Hepatotoxicity. Shinde V; Stöber R; Nemade H; Sotiriadou I; Hescheler J; Hengstler J; Sachinidis A Methods Mol Biol; 2015; 1250():225-40. PubMed ID: 26272146 [TBL] [Abstract][Full Text] [Related]
19. Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update. Teschke R; Vongdala N; Quan NV; Quy TN; Xuan TD Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638760 [TBL] [Abstract][Full Text] [Related]
20. Comparison of metabolism-mediated effects of pyrrolizidine alkaloids in a HepG2/C3A cell-S9 co-incubation system and quantification of their glutathione conjugates. Tamta H; Pawar RS; Wamer WG; Grundel E; Krynitsky AJ; Rader JI Xenobiotica; 2012 Oct; 42(10):1038-48. PubMed ID: 22519982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]